Publikationen, an denen er mitarbeitet María Fernanda Borges (79)

2023

  1. 2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1

  2. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies

    European Journal of Medicinal Chemistry, Vol. 248

  3. Modulating Cytotoxicity with Lego-like Chemistry: Upgrading Mitochondriotropic Antioxidants with Prototypical Cationic Carrier Bricks

    Journal of Medicinal Chemistry, Vol. 66, Núm. 3, pp. 1835-1851

  4. Propargylamine: an important moiety in drug discovery

    Future Medicinal Chemistry, Vol. 15, Núm. 1, pp. 211-224

2022

  1. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

    Molecules, Vol. 27, Núm. 3

  2. Design and synthesis of chromone-based monoamine oxidase B inhibitors with improved drug-like properties

    European Journal of Medicinal Chemistry, Vol. 239

  3. Thiocoumarins: From the Synthesis to the Biological Applications

    Molecules, Vol. 27, Núm. 15

2021

  1. 4-Oxoquinolines and monoamine oxidase: When tautomerism matters

    European Journal of Medicinal Chemistry, Vol. 213

  2. Chemical and biological analysis of 4-acyloxy-3-nitrocoumarins as trypanocidal agents

    Arabian Journal of Chemistry, Vol. 14, Núm. 3

  3. Computer-aided Design of Coumarins for Neurodegenerative Diseases: Trends of the Last Decade

    Current topics in medicinal chemistry, Vol. 21, Núm. 25, pp. 2245-2257

  4. Study of a Selected Series of 3- and 4-Arylcoumarins as Antifungal Agents against Dermatophytic Fungi: T. rubrum and T. mentagrophytes

    ChemistrySelect, Vol. 6, Núm. 37, pp. 9981-9989

2020

  1. Adenosine receptor ligands: Coumarin–Chalcone hybrids as modulating agents on the activity of hARs

    Molecules, Vol. 25, Núm. 18

  2. Exploring the multi-target performance of mitochondriotropic antioxidants against the pivotal Alzheimer’s disease pathophysiological hallmarks

    Molecules, Vol. 25, Núm. 2

  3. Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans

    International Journal of Biological Macromolecules, Vol. 162, pp. 774-780

  4. Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists

    Journal of Medicinal Chemistry, Vol. 63, Núm. 5, pp. 2577-2587

2019

  1. Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents

    European Journal of Medicinal Chemistry, Vol. 174, pp. 116-129

  2. Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction

    European Journal of Medicinal Chemistry, Vol. 167, pp. 525-545

  3. Insights into the discovery of novel neuroprotective agents: A comparative study between sulfanylcinnamic acid derivatives and related phenolic analogues

    Molecules, Vol. 24, Núm. 23

2018

  1. Correction to: Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors (Journal of Medicinal Chemistry (2016) 59 (5879-5893) DOI: 10.1021/acs.jmedchem.6b00527)

    Journal of Medicinal Chemistry

  2. Coumarins and adenosine receptors: New perceptions in structure–affinity relationships

    Chemical Biology and Drug Design, Vol. 91, Núm. 1, pp. 245-256